Skip to content
Screener

Stryker SYK Q2 2025 earnings

Reported July 31, 2025 · After market close

Revenue$6.0BBeat by $85.9M
EPS$3.13Beat by $0.06
Revenue estimate$5.9B
EPS estimate$3.07

Next report

Oct 29, 2026 (In 3 weeks)
Revenue estimate$6.6B
EPS estimate$3.56

Financials

Q2 2025

Income statement

See full
Revenue$6.0B+11.1%
Gross profit$3.8B+12.4%
Operating income$1.1B+5.9%
Net income$884.0M+7.2%
EPS (diluted)$2.29+7.0%

Balance sheet

See full
Cash & equivalents$2.4B+26.7%
Total debt$16.7B+35.4%
Total assets$46.3B+18.4%

Cash flow

See full
Operating cash flow$1.1B+75.5%
CapEx$183.0M+20.4%
Free cash flow$928.0M+92.9%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$147.69B+14.1%
Enterprise value$162.06B+15.8%
P/E50.6×+13.1×
P/S6.2×+0.1×

Profitability

See full
Gross margin64.1%+0.5pp
Operating margin15.2%-4.5pp
Net margin12.3%-3.9pp
FCF margin16.9%+3.8pp

Returns & leverage

See full
Current ratio1.8×+0.1×

Segments

By product

See full
Medical$990.0M+9.0%
Trauma and Extremities$957.0M+15.0%
Endoscopy$899.0M+17.1%
Instruments$768.0M+10.0%
Knees$640.0M+6.3%

By segment

See full
MedSurg and Neurotechnology:$3.8B+17.3%
Orthopaedics:$2.3B+2.0%

FAQ

When did Stryker report Q2 2025 earnings?
Stryker (SYK) reported Q2 2025 earnings on July 31, 2025 after market close.
What were Stryker's Q2 2025 revenue and EPS?
Stryker reported revenue of $6.0B and eps of $3.13 for Q2 2025.
Did Stryker beat estimates in Q2 2025?
Revenue beat the consensus estimate of $5.9B by $85.9M. EPS beat the consensus estimate of $3.07 by $0.06.
How did Stryker's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.1% from $5.4B a year earlier and eps grew 11.4% from $2.81.
Where can I find Stryker's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000310764-25-000103) and the 10-Q periodic report (0000310764-25-000107) directly on SEC EDGAR. The filing index links above go to sec.gov.